Cutaneous malignancies in chronic lymphocytic leukemia.

Bibliographic Details
Title: Cutaneous malignancies in chronic lymphocytic leukemia.
Authors: Zilberg, Catherine, Ferguson, Angela L., Lyons, James G., Gupta, Ruta, Fuller, Stephen J., Damian, Diona L.
Source: Journal of Dermatology; Mar2024, Vol. 51 Issue 3, p353-364, 12p
Abstract: Chronic lymphocytic leukemia (CLL) is a common lymphoid malignancy that is associated with an increased risk of developing cutaneous malignancies. Clinical outcomes for these malignancies, including melanoma and keratinocyte cancers (KC), are worse for patients with CLL. Individuals with CLL develop an immunodeficiency of both the adaptive and innate immune system, which plays a role in the increased prevalence of skin cancers. This review focuses on the complex interplay between genetics, immunity, and pathogens that influence the cellular composition and biology of skin tumors and their microenvironment in CLL patients, and in comparison with other chronic hematological malignancies. It is paramount for dermatologists to be aware of the association between CLL (and chronic hematological malignancies more broadly) and cutaneous malignancies. This is a high‐risk population who require regular and vigorous dermatologic follow‐up. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Dermatology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
More Details
ISSN:03852407
DOI:10.1111/1346-8138.17126
Published in:Journal of Dermatology
Language:English